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Brief Communications
Working Memory Capacity Predicts Dopamine Synthesis
Capacity in the Human Striatum
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Evidence from psychopharmacological research has revealed that dopamine receptor agents have opposite effects on cognitive function
depending on baseline levels of workingmemory capacity. These contrasting effects have been interpreted to reflect differential baseline
levels of dopamine. Here we demonstrate for the first time that working memory capacity as measured by listening span predicts
dopamine synthesis capacity in the striatum, indicating that subjects with lowworkingmemory capacity have lowDA synthesis capacity
in the striatum, whereas subjects with high working memory capacity have high DA synthesis capacity in the striatum.
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Introduction
The mesocorticolimbic dopamine (DA) system is known to play
a role in cognitive processes, including workingmemory (Brozo-
ski et al., 1979). This form of memory refers to the active “on-
line” maintenance andmanipulation of information over a short
interval of time (Goldman-Rakic, 1995) and has been associated
most commonly with the prefrontal cortex (PFC) (Fuster, 1989).
Evidence from studies with experimental animals suggest an “in-
verted U”-shaped function, by which both insufficient as well as
excessive levels of DAD1 receptor stimulation in the PFC impairs
working memory (Sawaguchi and Goldman-Rakic, 1991; Wil-
liams and Goldman-Rakic, 1995; Arnsten, 1998). This is evi-
denced, for example, by work with experimental animals show-
ing that D1 receptor stimulation improved poor working
memory performance that was accompanied by low in vivo DA
levels in the PFC, but impaired good performance that was ac-
companied by high DA levels in the PFC (Granon et al., 2000;
Floresco and Phillips, 2001; Phillips et al., 2004). A similar mech-
anismmay exist for the striatum (Frank andO’Reilly, 2006; Pezze
et al., 2007), which is strongly connected with the PFC in so-
called frontostriatal circuits (Alexander et al., 1986). An inverted
U-shaped relationship between baseline DA levels and cognitive
performancemay also underlie contrasting effects of dopaminer-
gic drugs in humans (Cools et al., 2001, 2007;Mattay et al., 2003).
Thus, psychopharmacological studies in humans have shown
that the effects of the administration of DA receptor agents on
cognition (as well as serum prolactin levels) depend on baseline
levels of workingmemory capacity asmeasuredwith the listening
span test (Daneman and Carpenter, 1980; Salthouse and Bab-
cock, 1991), with diametrically opposite effects in subjects with
high and low listening span (Kimberg et al., 1997; Mattay et al.,
2000; Kimberg and D’Esposito, 2003; Gibbs and D’Esposito,
2005, 2006; Frank and O’Reilly, 2006; Cools et al., 2007). Specif-
ically, administration ofDA receptor agonists improves cognitive
performance [e.g., set shifting (Kimberg et al., 1997; Frank and
O’Reilly, 2006; Cools et al., 2007), working memory updating
(Mehta et al., 2000; Frank andO’Reilly, 2006) andworkingmem-
ory retrieval (Gibbs and D’Esposito, 2005)] in subjects with low
span, but impairs performance in subjects with high span. Based
on evidence from studies with experimental animals (Williams
andGoldman-Rakic, 1995; Zahrt et al., 1997; Arnsten, 1998; Phil-
lips et al., 2004), these contrasting effects of DA agents have been
interpreted to reflect differential baseline levels of DA, with low
span corresponding to low baseline levels of DA and high span
corresponding to high baseline levels of DA. This hypothesis is
consistent with a number of positron emission tomography
(PET) studies that have demonstrated associations between
(working) memory performance and the degree of DA receptor
binding (Ba¨ckman et al., 2000; Aalto et al., 2005). However, there
is currently no data in direct support of the hypothesis that lis-
tening span predicts baseline DA levels. The present study fills
this gap by demonstrating that workingmemory capacity asmea-
sured with the listening span test predicts DA synthesis capacity
in the striatum.
Materials andMethods
Subjects. The University of California Berkeley Committee for the Pro-
tection of Human Subjects approved the procedures, which were in ac-
cord with the Helsinki Declaration of 1975. Twenty-five (three male)
subjects who previously participated in a pharmacological study on the
effects of bromocriptine (Cools et al., 2007) were invited to participate in
this study. Eleven female subjects (mean age, 22.2; 2 SD) accepted and
were eligible to participate in the PET scan (for additional demographic
details, see Table 1). The relationship between the drug effects on the
tasks administered in that previous study and baseline DA synthesis will
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be reported in a separate publication (R. Cools, M. J. Frank, S. E. Gibbs,
A. Miyakawa, W. Jagust, and M. D’Esposito, unpublished observation).
Subjectswere screened for psychiatric andneurological disorders, gave
written informed consent, and were compensated for participation. Ex-
clusion criteria were any history of cardiac, hepatic, renal, pulmonary,
neurological, psychiatric, or gastrointestinal disorders, an episode of loss
of consciousness, use of psychotropic drugs, sleeping pills, and heavy
marihuana use (10 times in a lifetime).
As part of the previous study, subjects completed a battery of neuro-
psychological tests, which included (1) the listening version (Salthouse
and Babcock, 1991) of a reading span task modeled after that used by
Daneman and Carpenter (1980), (2) the North American Adult Reading
Test (Nelson, 1982), (3) the Beck Depression Inventory (Beck et al.,
1961), (4) the forward digit span, (5) the forward and backward spatial
span (Corsi block-tapping test) (Milner, 1971), (6) the Wisconsin Card
SortingTest (WCST) (Grant andBerg, 1948), (7) a paper andpen version
of the Stroop task (Stroop, 1935), (8) a letter fluency task (Benton, 1968),
(9) the Montreal Cognitive Assessment (MoCA) (Nasreddine et al.,
2005) (analogous to the Mini Mental State Examination, to assess mild
cognitive impairment), and (10) the Barratt Impulsiveness Scale (Patton
et al., 1995) (Table 1).
Listening span test. Working memory capacity was investigated with
the listening version (Salthouse and Babcock, 1991) of a reading span
taskmodeled after that used byDaneman andCarpenter (1980). Subjects
listened to sets of two to seven sentences and completed a written factual
verification question for the content of each sentence. After the last sen-
tence of each set, subjects recalled the final word of each sentence in the
order in which they were presented. The span represents the maximum
number of sentences performed correctly on at least two out of three
trials (for more details, see Salthouse and Babcock, 1991).
PET imaging. Subjects underwent a single positron emission tomog-
raphy scanwith the tracer 6-[ 18F]fluoro-L-m-tyrosine (FMT). The tracer
was synthesized with a modification of the procedure as previously re-
ported (Namavari et al., 1993). FMT is comparable with themore widely
used [18F]fluorodopa, with the exception that it is not a substrate for
O-methylation and therefore provides higher signal-to-noise images. Be-
cause it tracks decarboxylase activity it is an index of presynaptic dopa-
mine synthesis capacity, that is, about processes that occur in striatal
terminals of midbrain dopamine neurons (DeJesus et al., 1997; Jordan et
al., 1997). All subjects were scanned60 min after administration of an
oral dose of 2.5 mg/kg of the peripheral decarboxylase inhibitor carbi-
dopa to increase brain uptake of the tracer. Participants were positioned
on the scanner bed with a pillow and an elastic band to comfortably
restrict head motion. Images were obtained on a Siemens (Erlangen,
Germany) ECAT EXACT HR scanner in three-dimensional (3D) acqui-
sition mode. A 10 min transmission scan was obtained for attenuation
correction, then2.5 mCi of FMTwere subsequently injected as a bolus
in an antecubital vein and a dynamic acquisition sequence in 3D mode
was obtained: 4 1min, 3 2min, 3 3min, and 14 5min for a total
of 89 min of scan time.
PET image analysis. Data were reconstructed using an ordered subset
expectation maximization algorithm with weighted attenuation, an im-
age size of 256 256, and six iterations with 16 subsets. A Gaussian filter
with 6 mm full-width at half-maximum was applied, with a scatter cor-
rection. Images were evaluated for subject motion and realigned as nec-
essary using algorithms implemented in SPM2.
PET images were then coregistered to each individual’s high-
resolution MP-FLASH (magnetization-prepared fast low-angle shot
three-dimensional sequence) (0.875 0.875 1.54 mm) obtained dur-
ing the previous magnetic resonance imaging (MRI) study using a 12-
parameter affine algorithm implemented in SPM2. This permitted the
use of the high-resolution MRI image for anatomical verification of the
localization of functional PET ROIs. Bilateral cerebellar ROIs were used
as a reference ROI in conjunction with ROIs in striatum and a simplified
reference tissue model with a graphical analysis approach (Patlak and
Blasberg, 1985; Lammertsma and Hume, 1996). This leads to an influx
constant Ki, which reflects regional FMT uptake scaled to the volume of
distribution in the reference region.
To test hypotheses about DA differences in subregions of the striatum,
we defined ROIs in the right and left caudate and putamen. An axial
image representing the sum of the last four emission scans of the PET
scanning session (4  5 min frames) was coregistered to the high-
resolution magnetic resonance (MR) scan. ROIs were drawn on these
images (Wang et al., 1996; Volkow et al., 1998), using the atlas of Ta-
lairach and Tournoux (1988) to delineate the caudate and putamen.
Regions were drawn on data in native space to preserve differences in
tracer uptake caused by anatomical variability between subjects.We have
previously demonstrated the ability to draw ROIs with high inter-rater
reliability (Klein et al., 1997). The Patlak model was fitted with dynamic
data from each ROI from 24 to 89 min, when the regression is highly
linear (r0.99).
Spearman r correlations were calculated between listening spans (ob-
tained as part of the previous study) and Ki values from each of the four
ROIs (obtained as part of the current PET study). In addition, one-way
ANOVA was used to compare Ki values directly between high- and low-
span subjects. To this end, we divided subjects into a high-span and
low-span subgroups according to previous studies (Kimberg et al., 1997;
Gibbs andD’Esposito, 2005, 2006); subjects with a span of four or greater
(n  5) were considered high-span subjects, whereas those with a span
less than four (n 6) were considered low-span subjects.
Results
There was a significant positive correlation between listening
span and Ki values from the left caudate nucleus (r(11)  0.68,
ptwo-tailed 0.022) (Fig. 1). This correlation remained significant
after correction for age (r(8)  0.65, ptwo-tailed  0.04). Similar
positive correlationswere observed between listening span andKi
values from the left putamen (r(11)  0.54, ptwo-tailed  0.089),
from the right caudate nucleus (r(11) 0.51, ptwo-tailed 0.1) and
Table 1. Neuropsychological data
Test Low-span High-span
Listening span* 2.8 (0.6) 4.0 (0.0)
Age 21.5 (0.8) 23.0 (2.8)
NAART errors 13 (1.4) 11 (3.2)
BDI 2.5 (2.0) 6.2 (4.0)
Forward digit span 8.8 (1.5) 10.4 (1.7)
Spatial span 20.6 (3.2) 22.6 (0.9)
WCST, % perseverative errors 6.8 (2.1) 7.0 (0.8)
WCST, % nonperseverative errors 8.8 (4.2) 5.8 (2.1)
Letter fluency 43.0 (8.6) 48.8 (7.1)
MoCA 28.0 (2.0) 28.8 (1.1)
Barratt score 60.2 (15.4) 74.0 (12.6)
*Significantly different between the low- and high-span groups. There were no significant differences in perfor-
mance on any of the background measures. NAART, North American Adult Reading Test (Nelson, 1982); BDI, Beck
Depression Inventory (Beck et al., 1961);WCST,Wisconsin Card Sorting Test (Grant andBerg, 1948);MoCA,Montreal
Cognitive Assessment (Nasreddine et al., 2005).
Figure1. The correlationbetween listening spanandKivalues fromthe left caudatenucleus.
Cools et al. • Dopamine and Working Memory Capacity J. Neurosci., January 30, 2008 • 28(5):1208–1212 • 1209
from the right putamen (r(11) 0.45, ptwo-tailed 0.17), but these
did not reach significance.
Supplemental analyses revealed that there were no significant
(Pearson’s r) correlations between Ki values from any of the four
ROIs and performance on any of the other neuropsychological
tests (all r(11) values  0.01, all p values  0.6; MoCA, all r(11)
values 0.4, all p values 0.2; Stroop interference score, all r(11)
values 0.02, all p values 0.7; spatial span, all r(10) values 0.4,
all p values  0.24 (one spatial span dataset missing); forward
digit span, r(11) values 0.35, all p values 0.3; verbal fluency, all
r(11) values 0.06, all p values 0.8; WCST, percentage of per-
severative errors, all r(8) values0.6, all p values 0.1;WCST,
percentage of nonperseverative errors, all r(8) values0.6, all p
values  0.1; three WCST datasets missing; all p values two
tailed).
In Figure 2, we show the mean raw axial (MR coregistered)
whole-brain FMT PET Ki image from the high-span group (left
panel) and the low-span group (middle). ANOVA revealed sig-
nificantly lowerKi values in the low-span group than in the high-
span group for the left caudate nucleus (F(1,9) 5.8, ptwo-tailed
0.04) and the left putamen (F(1,9)  5.0, ptwo-tailed  0.05). Dif-
ferences in terms of values from the right-sided ROIs did not
reach significance (right caudate nucleus, F(1,9)  2.9; right pu-
tamen, F(1,9) 2.1).
Discussion
Here, we demonstrate for the first time that working memory
capacity as measured with the listening span test is associated
with DA synthesis capacity in the striatum; a significant positive
correlation was found between DA synthesis capacity in the left
caudate nucleus and listening span (Salthouse and Babcock,
1991), indicating that subjects with low working memory capac-
ity have low DA synthesis rates in the striatum, whereas subjects
with highworkingmemory capacity have highDA synthesis rates
in the striatum.DA synthesis capacitywas also lower for low-span
subjects in the left putamen, the right caudate nucleus and the
right putamen, but these effects did not reach significance, with
the left lateralization of the effect possibly reflecting the verbal
nature of the task. These data provide empirical evidence for the
pervasive, but hitherto untested hypothesis that the dependency
of dopaminergic drug effects on baseline working memory ca-
pacity reflects differential baseline levels of DA function. For ex-
ample, theD2 receptor agonist bromocriptine reduced persevera-
tive responding on theWCST in low-span subjects, but increased
perseverative responding on the WCST in high-span subjects
(Kimberg et al., 1997). Similarly, bromocriptine improved atten-
tional switching on a working memory paradigm in low-span
subjects but, if anything, impaired switching in high-span sub-
jects (Cools et al., 2007). These latter contrasting effects of bro-
mocriptine on switching difficulty were accompanied by oppo-
site effects on neural activity in the striatum, as measured with
functional magnetic resonance imaging; bromocriptine potenti-
ated task-related striatal activity in low-span subjects, but if any-
thing attenuated striatal activity in high-span subjects. These ef-
fects were interpreted to reflect differential baseline levels of DA
function in the striatum (Cools et al., 2007). The present study
provides direct evidence for this hypothesis and confirms that
workingmemory capacity predicts baseline levels ofDA synthesis
in the striatum.
A significant association between listening span and striatal
dopamine synthesis capacity did not extend to other tests such as
the spatial span test. Based on recent theoretical models (Frank et
al., 2001), we speculate that this specificity reflects disproportion-
ate sensitivity to changes in striatal dopamine of listening span
performance, which, unlike the other tests, requires the rapid
updating of currently relevant representations in working mem-
ory. Performance on, for example, the spatial span test depends
more readily on the stable maintenance, rather than the rapid
updating, of those representations, which may implicate frontal
rather than striatal dopamine. The hypothesis that performance
on other working memory tests are also associated with dopa-
mine synthesis capacity is consistent with a recent observation
that performance on the two-back working memory task corre-
lated with the degree of task-related dopamine displacement
from the D2 receptor as measured with [
11C]FLB 457 (a high-
affinity radioligand for extrastriatal D2-like receptors) PET
(Aalto et al., 2005). Indeed, the degree of task-related dopamine
displacement may well depend on dopamine synthesis capacity.
Until now, evidence for an optimal level of DA comes primar-
ily from animal studies investigating the effects ofDAD1 receptor
stimulation in the PFC, with low doses improving, but high doses
impairing working memory performance (Zahrt et al., 1997;
Arnsten, 1998; Granon et al., 2000). An important implication of
the present study is that a similar mechanism must exist for DA
D2 receptor stimulation in the striatum of humans, who exhibit
opposite behavioral effects as a function of working memory ca-
pacity after administration of relatively selective D2 receptor
agents [such as bromocriptine (Kimberg et al., 1997; Gibbs and
D’Esposito, 2005; Cools et al., 2007), cabergoline (Frank and
O’Reilly, 2006), and haloperidol (Frank and O’Reilly, 2006)]. In-
deed, D2 receptors aremuchmore abundant in the striatum than
in the PFC (Camps et al., 1989). The conclusion that an optimal
level of DA function exists not only in the PFC, but also in the
striatum, is also consistentwith a recent observation that infusion
into the (ventral) striatum of a low, but not a high DA receptor
agonist dose improved accuracy on an attentional choice reaction
time task (Pezze et al., 2007).
Although the present study indicates that listening span re-
flects striatal DA synthesis capacity, it should be noted that it does
not directly elucidate the precise pharmacological mechanism
underlying the contrasting effects of D2 receptor agents. One
possibility is that a reduction in DA synthesis induces super-
sensitivity and/or increased (upregulated) density of striatal DA
receptors, and thus greater sensitivity to the effects of DA (D2)
receptor agents. This hypothesis can account for the observation
that low-span subjects are disproportionately sensitive not only
to the effects of DA D2 receptor agonists, but also to those of DA
D2 receptor antagonists, such as haloperidol (Frank andO’Reilly,
2006), and can be tested directly using PET imaging with ligands
Figure 2. The mean raw axial (MR coregistered) whole-brain FMT PET Ki images from the
high-spangroup (left) and from the low-spangroup (right) overlaid on anormalizedMR image.
Data represent Ki values. The right is right according to neurological conventions.
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such as the DA D2 receptor antagonists [
11C]raclopride or
[18F]fallypride.
Intriguingly, the relationship between baselineworkingmem-
ory capacity and DA receptor stimulation with the mixed D1/D2
receptor agonist pergolide is opposite to that seen for the rela-
tively selective D2 receptor agents. In contrast to bromocriptine,
administration of pergolide improved working memory perfor-
mance in high-span subjects, while impairing it in low-span sub-
jects (Kimberg and D’Esposito, 2003; Gibbs and D’Esposito,
2006). This implies that administration of pergolide improves
performance in subjects with high DA synthesis capacity in the
striatum, but impairs it in subjectswith lowDA synthesis capacity
in the striatum. The apparent discrepancy between the effects of
pergolide and bromocriptine may reflect differential selectively
of the drugs forD1 andD2 receptors respectively and the resulting
differential (frontal versus striatal) site of modulation. Specifi-
cally, the effects of pergolidemay reflect modulation of DA in the
PFC, where D2 receptors are less abundant, whereas the effects of
selectiveD2 receptor agentsmay reflect amodulation ofDA in the
striatum. The opposite relationships between working memory
capacity, which we demonstrate is associated with striatal DA
synthesis, and DA receptor stimulation with pergolide and bro-
mocriptine may thus reflect the known reciprocal relationship
between DA in the PFC and DA in the striatum (Pycock et al.,
1980). This hypothesis is consistent with the behaviorally selec-
tive effects of pergolide on working memory maintenance (Kim-
berg and D’Esposito, 2003) and those of bromocriptine on set
shifting (Kimberg et al., 1997; Cools et al., 2007), particularly
given that these two processes have been hypothesized to depend
on DA (D1 receptor function) in the PFC and DA (D2 receptor
function) in the striatum respectively (Crofts et al., 2001; Frank et
al., 2001; Bilder et al., 2004; Seamans and Yang, 2004; Cools et al.,
2007). This proposal needs to be tested in future studies with
neurochemical PET imaging methods that allow the direct com-
parison of DA D1 receptor function in the PFC (e.g., using the
ligand [11C]NNC 112 or [11C]SCH 23390) (both dopamine D1
receptor antagonist ligands) with DAD2 receptor function in the
striatum.
The present results were obtained in a relatively small sample
of female volunteers. The significance of both the group differ-
ence as well as the continuous measure suggests that the differ-
ence will hold in larger groups, to be tested in future studies. The
inclusion of females onlymay have affected variability in baseline
levels of dopaminergic neurotransmission, which likely depend
on estrogen levels. Future work should address directly the rela-
tionship between dopamine, working memory and menstrual
cycle and will help to determine whether the present results are
trait and/or state dependent.
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